Repros Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.01.18	Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Repros Therapeutics Inc. In The Southern District Of Texas Houston Division (PR Newswire)
28.12.17	Lifshitz & Miller LLP Announces Investigation of Almost Family, Inc., FNB Bancorp, Repros Therapeutics Inc., Snyder's-Lance, Inc., Southcross Energy Partners, L.P., Stone Energy Corporation and... (PR Newswire)
18.12.17	SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Repros Therapeutics, Inc. - RPRX (PR Newswire)
18.12.17	FDA Nod For ACRS, PETX Disappoints, QGEN & OXFD Make Peace, SGRY Fitter (RTTNews)
17.11.17	Could Erectile Dysfunction Help Diagnose Diabetes in Men? (PR Newswire)
18.07.17	FDA Nod For PBYI, ANIK Sees 23-26% Revenue Growth, CBAY Abuzz, RPRX Plunges (RTTNews)
17.07.17	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Repros Therapeutics Inc. (RPRX) (PR Newswire)
17.07.17	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repros Therapeutics, Inc. - RPRX (PR Newswire)
18.05.17	SNDX Rises On Entinostat Data, Kalydeco Gets FDA Nod, Concert Fails To Enthrall (RTTNews)
18.04.17	Gainers & Losers Of Apr.17: CBLI, INFI, PBYI, OMED, INCY... (RTTNews)
13.09.16	RPRX On Track Across The Pond, CERC Gets Funded, Data Gives FOMX A Facelift (RTTNews)
08.09.16	CGNT Abuzz, Retrophin's DUET Hits Right Notes, Watch Out For RPRX (RTTNews)
02.06.16	No Objection To EverSweet, CTRV Awaits Data In Q4, Two Down, One To Go For DERM (RTTNews)
19.05.16	FDA Greenlights Bladder Cancer Drug, RPRX Up 30% After-hours, Mega Leap For MGNX (RTTNews)
17.02.16	FLXN Flexes Muscles, FDA Approves Broader Use Of Harvoni, Headache For TNXP (RTTNews)
10.08.15	Repros Loss Narrows On Lower Research Expenses (RTTNews)
26.09.14	Repros Granted Type B Pre-NDA Meeting With FDA In First Half Of November (RTTNews)
19.09.14	It's Time To Cross The T's... (RTTNews)
11.08.14	Repros Therapeutics Q2 Loss Widens (RTTNews)
12.05.14	Repros Therapeutics Q1 Loss Narrows (RTTNews)
18.03.14	ATEC Sees Growth, FPRX Gets High-Five, RNA Walks The Talk, RPRX On The Move (RTTNews)
17.03.14	Repros Allowed To Conduct Phase 1, 2 Studies Of Oral Proellex - Quick Facts (RTTNews)
10.02.14	Repros Announces Additional Results From ZA-300 Six Month Study Of Androxal (RTTNews)
25.11.13	Repros Therapeutics To Meet FDA Regarding Talks On Androxal Efficacy Studies (RTTNews)
07.11.13	Repros Therapeutics Q3 Loss Widens (RTTNews)
05.11.13	ACUR To Meet With FDA, CYTX Does A Deal, NNVC Renews Contract, RGLS On Watch (RTTNews)
05.11.13	Repros Receives FDA Guidance For Proellex Low Dose Oral Uterine Fibroid Program (RTTNews)
23.10.13	EPZM, MDVN On Watch, MYGN In Legal Spat With BRLI, ONVO's 3D Story Gets Better (RTTNews)
22.10.13	Early Briefing and Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. (PR Newswire)
25.09.13	Pre-Market Review: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. (PR Newswire)
23.09.13	Critical Alerts For LinkedIn, Priceline, Repros Therapeutics, Sohu.com, and Vipshop Released By InvestorsObserver (PR Newswire)
18.09.13	Repros Therapeutics Reports Additional Results For Study ZA-302 (RTTNews)
17.09.13	KYTH Gets A Facelift, PSTI To Resume Study, One Up, Two To Go For NBY (RTTNews)
29.08.13	Clinical Trials, Pipeline Developments, Financial Results, and New Appointments - Research Report on Amarin, Immunomedics, Seattle Genetics, Repros Therapeutics, and LifePoint (PR Newswire)
20.08.13	Pre-Market Analysis: Dendreon Corp., Stryker Corp., Novartis AG, and Repros Therapeutics Inc. (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sika	221.70	1.65 %	K V
UBS Group	29.83	1.05 %	K V
Roche Hldg G	269.20	0.86 %	K V
Part Grp Hldg	1’310.00	0.85 %	K V
Lonza Grp	560.40	0.50 %	K V
Geberit	503.60	-0.43 %	K V
Zurich Insur Gr	541.60	-1.02 %	K V
CieFinRichemont	139.50	-1.03 %	K V
Swiss Re	133.40	-1.04 %	K V
Kuehne+Nagel Int	202.80	-2.22 %	K V

Nachrichten zu Repros Therapeutics Inc

Aktien Top/Flop

Meistgelesene Nachrichten